Will Sargent will leverage deep experience to meet the increasing demand for services in the life sciences industry.
YARDLEY, Penn. – October 13, 2022 – Herspiegel, a leading provider of commercial strategy and implementation services to pharmaceutical and biotech industries, announced today that seasoned strategist, Will Sargent, has been promoted to Principal at the company. In his new role, he will use his depth of experience and ability to help biopharma clients through an increasingly complex healthcare landscape to get new therapies to patients and optimize commercial outcomes.
“Our clients are grappling with complex commercial strategy and execution issues in the pharmaceutical industry,” said Beth Schurman, Partner and Chief Operating Officer at Herspiegel. “Will’s ability to devise insight-driven strategy, design innovative programs, and drive execution with impact has proven invaluable to clients and to our company as a whole.”
Will leverages his engineering background and passion for solving large-scale commercial problems using new technologies and applying them to complex biopharma challenges. He delivers innovative solutions that repeatedly drive performance and positive outcomes for our clients.
Will expressed his excitement at taking on this new role, “I am a lifelong learner, and I am energized by mentoring talent, teaching others the skills and knowledge I have learned while watching them grow. This is at the foundation of Herspiegel’s success to mentor talent and enable individuals to grow at their own pace to succeed.”
Working across Herspiegel service lines, Will has demonstrated continued success in patient services design and support. In one example, our client increased adherence and compliance, improving the patient’s experience while reducing costs more than 15%. His accomplishments in marketing and commercial services include revising a pharma companies strategy in the field to leverage telehealth and non-personal communication, developing a virtual sales representative strategy early on in the COVID-19 pandemic enabling his client to maintain their sales trajectory despite significant disruption in the market.
Prior to Herspiegel, Will spent several years at Merck installing operational best practices and supporting executive strategy, his industry experience includes participating in 16 product launches, medical devices companies, as well as small biotech launching their first commercial products. He has experience in oncology, diabetes, CNS, pain, rare diseases, digital health, and connected devices. Will holds a Bachelor’s degree from the US Naval Academy in Mechanical Engineering and an MBA from the University of North Carolina. He is also a certified Lean Six Sigma Black Belt.
Herspiegel is a leading provider of commercialization services, optimizing business outcomes for biotech start-ups executing their first commercialization and the world’s largest pharmaceutical companies. Our core service lines include launch readiness, commercial and marketing excellence, market access, medical affairs, and patient services strategy. Find out more at www.herspiegelconsulting.com